John P. Longenecker Phd - Mar 3, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Mar 3, 2022
Transactions value $
-$426,475
Form type
4
Date filed
3/7/2022, 07:03 PM
Previous filing
Jun 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $75.7K +7K +37.19% $10.81 25.8K Mar 3, 2022 Direct
transaction PCRX Common Stock Sale -$502K -7K -27.11% $71.74 18.8K Mar 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -7K -100% $0.00* 0 Mar 3, 2022 Common Stock 7K $10.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012.